IRIS
DANESE, Silvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.444
AS - Asia 15.673
EU - Europa 4.819
SA - Sud America 3.111
AF - Africa 854
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 46
AN - Antartide 1
Totale 52.005
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.941
SG - Singapore 10.162
BR - Brasile 2.589
CN - Cina 2.195
VN - Vietnam 1.521
FI - Finlandia 1.023
IE - Irlanda 718
NG - Nigeria 595
DE - Germania 557
FR - Francia 479
GB - Regno Unito 399
HK - Hong Kong 398
IT - Italia 360
CA - Canada 307
IN - India 258
NL - Olanda 255
SE - Svezia 209
AR - Argentina 190
TR - Turchia 172
BD - Bangladesh 151
RU - Federazione Russa 146
MX - Messico 119
IQ - Iraq 117
ES - Italia 97
BE - Belgio 95
PL - Polonia 89
UA - Ucraina 85
IL - Israele 83
JP - Giappone 82
ZA - Sudafrica 82
EC - Ecuador 77
ID - Indonesia 66
CL - Cile 65
RO - Romania 55
CO - Colombia 54
PK - Pakistan 51
SA - Arabia Saudita 48
VE - Venezuela 48
AU - Australia 47
A2 - ???statistics.table.value.countryCode.A2??? 41
PY - Paraguay 39
EG - Egitto 38
PH - Filippine 38
UZ - Uzbekistan 38
MA - Marocco 37
CZ - Repubblica Ceca 35
GR - Grecia 34
JO - Giordania 30
IR - Iran 28
AE - Emirati Arabi Uniti 26
LT - Lituania 26
KR - Corea 22
MY - Malesia 22
TN - Tunisia 22
AT - Austria 21
DZ - Algeria 21
KE - Kenya 20
KZ - Kazakistan 20
NP - Nepal 19
AZ - Azerbaigian 18
CH - Svizzera 18
UY - Uruguay 18
NO - Norvegia 17
PE - Perù 17
AL - Albania 16
PT - Portogallo 15
JM - Giamaica 14
LB - Libano 13
MD - Moldavia 13
CR - Costa Rica 12
DO - Repubblica Dominicana 11
ET - Etiopia 11
SY - Repubblica araba siriana 11
KG - Kirghizistan 10
BO - Bolivia 9
BY - Bielorussia 9
DK - Danimarca 9
OM - Oman 9
CY - Cipro 8
GT - Guatemala 8
PA - Panama 8
SN - Senegal 8
HN - Honduras 7
PS - Palestinian Territory 7
TH - Thailandia 7
HU - Ungheria 6
NZ - Nuova Zelanda 6
TW - Taiwan 6
BN - Brunei Darussalam 5
QA - Qatar 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
AO - Angola 4
BB - Barbados 4
BG - Bulgaria 4
GE - Georgia 4
GY - Guiana 4
KW - Kuwait 4
LV - Lettonia 4
MK - Macedonia 4
Totale 51.935
Salva come PNG Salva come JPEG
Città #
Singapore 4.876
Chandler 4.195
Wilmington 4.032
San Mateo 1.633
The Dalles 1.600
Ashburn 1.506
Ann Arbor 1.257
Dallas 1.131
Shanghai 1.125
Helsinki 1.019
San Jose 745
Lawrence 713
Princeton 713
Dublin 712
Leawood 703
Boardman 699
Benin City 589
Ho Chi Minh City 505
New York 483
Beijing 437
Paris 404
Hanoi 394
Woodbridge 378
Hong Kong 367
Fairfield 366
Amsterdam 238
São Paulo 200
London 191
Toronto 177
Columbus 164
Seattle 160
Los Angeles 158
Milan 106
Santa Clara 105
Norwalk 103
Phoenix 98
San Diego 95
Orem 93
Kocaeli 92
Rio de Janeiro 89
Brussels 86
Council Bluffs 82
Belo Horizonte 69
Da Nang 62
Warsaw 59
Haiphong 58
Falkenstein 56
Tokyo 55
Brasília 53
Munich 48
Campinas 47
Chennai 47
Redwood City 46
Houston 42
Pune 41
Johannesburg 40
Montreal 39
Brooklyn 38
Baghdad 36
Frankfurt am Main 36
Monmouth Junction 36
Moscow 36
Curitiba 34
Falls Church 34
Abbiategrasso 33
Clearwater 33
Mexico City 32
Tashkent 32
Chicago 31
Porto Alegre 31
Atlanta 29
Cambridge 29
San Francisco 29
Amman 28
Buffalo 28
Biên Hòa 26
Brno 26
Des Moines 26
Guayaquil 26
Boston 25
Dhaka 24
Hillsboro 24
Manchester 24
Quito 24
Salvador 24
Stockholm 24
Naples 23
Guarulhos 22
Mumbai 22
Goiânia 21
Redmond 21
Jakarta 20
Nairobi 20
Bắc Ninh 19
Istanbul 19
Las Vegas 19
Ninh Bình 19
Baku 18
Fortaleza 18
Ottawa 18
Totale 34.718
Salva come PNG Salva come JPEG
Nome #
Biological agents for ulcerative colitis : Hypes and hopes 306
Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion 266
Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial 193
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 151
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 149
Crohn's disease 148
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 146
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 143
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 134
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 132
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis 129
Endoscopic flexible treatment of Zenker's diverticulum: a modification of the needle-knife technique 125
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 125
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 125
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 125
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 124
Review article: optimal preparation for surgery in Crohn's disease 123
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 119
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 119
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 119
A NEW TOOL FOR PRE-COLONOSCOPY DYING OF THE COLONIC MUCOSA WITH ORAL MULTI MATRIX RELEASE TECHNOLOGY (MMX (R))-RELEASED METHYLENE BLUE: A PRELIMINARY STUDY 118
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease 118
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission : a case report 117
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 117
Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease 115
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies 114
Ulcerative Colitis 114
Intestinal microbiota in inflammatory bowel disease: Friend of foe? 113
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 113
Laparoscopic Surgery for Recurrent Crohn's Disease 112
Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go 112
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 110
Colitis-associated cancer: the dark side of inflammatory bowel disease 110
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 110
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 109
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 109
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 109
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study 107
Adalimumab in active ulcerative colitis: A "real-life" observational study 107
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study. 107
Imaging Modalities for Perianal Crohn's Disease 106
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease 106
Risk of postoperative recurrence and postoperative management of Crohn's disease 105
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 105
Second-Generation Corticosteroids for the Treatment of Crohn's Disease and Ulcerative Colitis: More Effective and Less Side Effects? 104
Accuracy of Diffusion-weighted Magnetic Resonance Imaging in Detecting Mucosal Healing and Treatment Response, and in Predicting Surgery, in Crohn's Disease 104
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 103
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis 103
Biological therapies for inflammatory bowel disease: Research drives clinics 102
Evolving strategies and goals of treatment in ulcerative colitis 102
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 102
Immune regulation by microvascular endothelial cells: Directing innate and adaptive immunity, coagulation, and inflammation 101
Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment 101
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 101
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 101
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD 101
Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice 100
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 99
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer 99
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease 99
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX® for mild-to-moderate ulcerative colitis 99
Dysregulated intracellular redox equilibrium in intestinal lamina propria T cells (LPT) contributes to mucosal inflammation 98
Accuracy of a new diagnostic tool in deep infiltrating endometriosis: Positron emission tomography-computed tomography with 16 alpha-[18F]fluoro-17 beta-estradiol 98
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 97
Vascular involvement in inflammatory bowel disease: Pathogenesis and clinical aspects 97
Thrombomodulin-activated protein C-endothelial protein C receptor pathway: A novel anti-inflammatory system in IBD 97
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 97
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter? 96
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 96
Management of IBD during the COVID-19 outbreak: resetting clinical priorities 96
IBD Of mice and men-shedding new light on IL-13 activity in IBD 95
Inflammatory bowel disease: the role of environmental factors 95
Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study 95
Review article: causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-alpha therapy 95
Adalimumab in ulcerative colitis: Ready for prime time 95
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 95
Methotrexate for Corticosteroid- Dependent Ulcerative Colitis: Results of a Placebo Randomized Controlled Trial 95
Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome. 95
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy 95
Perception of reproductive health in women with inflammatory bowel disease 94
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2 94
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 94
Emerging biologics in the treatment of inflammatory bowel disease : what is around the corner? 93
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients 93
Surgical rates in the era of biological therapy: up, down or unchanged? 93
Impact of Tumour Necrosis Factor Antagonists on Avoiding Surgery in Stricturing Crohn's Disease: A Tertiary Center Real-Life Experience 93
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 93
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 93
A Multidisciplinary Approach to Rectal Cancer Treatment in Ulcerative Colitis Results in High Rate of Restorative Minimally Invasive Surgery 92
Review article: Inherited thrombophilia in inflammatory bowel disease 92
Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes. 92
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT 92
Development and validation of the Nancy histological index for UC 91
Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients 91
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis 91
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study 91
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial 91
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 91
Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms' 90
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX® FOR MILD-TO-MODERATE ULCERATIVE COLITIS 90
Totale 11.046
Salva come PNG Salva come JPEG
Categoria #
all - tutte 365.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 365.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.872 0 0 0 0 0 0 0 0 0 982 25 865
2021/20224.321 216 55 132 871 39 48 127 555 391 708 944 235
2022/202310.525 1.608 443 1.060 1.208 899 954 32 942 1.830 867 553 129
2023/20245.142 439 531 1.153 220 179 616 231 276 98 90 425 884
2024/20257.680 223 196 74 214 228 940 358 979 985 1.837 812 834
2025/202617.533 2.913 1.132 1.323 1.821 576 647 5.919 1.047 1.064 1.091 0 0
Totale 52.723